13GFrazier Life Sciences Public Fund, L.P.1,755,116 5.9% of class · Oct 2, 2026New 5%+ stake
with Frazier Life Sciences XII, L.P., Fhmls XII, L.P., Fhmls XII, L.L.C., +3 more
No 13F filer matched
7.4% of class · Sep 30, 2026New 5%+ stake
273d ahead of 13F (1,035 sh) · +2,204,355
13.9% of class · Jul 16, 2026Unchanged
with Orbimed Capital GP VII LLC, OrbiMed Genesis GP LLC
16d ahead of 13F (4,127,987 sh) · no change
13GBoxer Holdings, LP3,149,310 13.3% of class · Jun 30, 2026New 5%+ stake
No 13F filer matched
13G/APoint72 Capital Advisors, Inc.1,173,396 5.0% of class · Jun 30, 2026Newly reported
No 13F filer matched
13G/AOpaleye, L.P.931,000 5.5% of class · Jun 30, 2026New 5%+ stake
No 13F filer matched
13G/AAbingworth Bioventures VII LP691,735 4.1% of class · Jun 30, 2026Newly reported
No 13F filer matched
13G/ASirenia Capital Management LP0 0.0% of class · Jun 30, 2026No shares held
No 13F filer matched
13D/AAtlas Venture Associates X, L.P.864,261 3.6% of class · May 26, 2026Newly reported
with Atlas Venture Opportunity Fund II, L.P., Atlas Venture Associates Opportunity II, LLC, Atlas Venture Associates Opportunity II, L.P., +6 more
No 13F filer matched